Stock Market Today: Dow Slips As Nasdaq Struggles; Oracle Hit, Salesforce Up (Live Coverage)

A broad sell-off in artificial‑intelligence–linked stocks pushed the S&P 500 and the Nasdaq composite below key technical levels, driven in part by a sharp decline in Oracle shares amid concerns over a multibillion‑dollar data‑center project. The weakness in Oracle and other AI names pressured the tech‑heavy Nasdaq, while Medline (MDLN) staged a strong debut as the largest IPO of the year, highlighting bifurcated flows between renewed IPO demand and risk‑off sentiment in AI/tech names. Investors should watch Oracle and other AI plays for follow‑through and monitor whether technical breaches trigger broader risk reduction across growth exposures.

Analysis

Market structure: The knee-jerk sell-off centered on ORCL’s data-center execution fears is compressing multiples of pure AI plays and software names while temporarily benefiting defensive and broad-cap hardware names (NVDA, AVGO) that look more like durable cash-flow stories. Expect correlated downside across AI-themed ETFs and concentrated large-cap tech baskets for days–weeks until ORCL guidance or NVDA prints stabilize flows; liquidity will be worst on large option expiries and rebalancings within 1–3 weeks.

Risk assessment: Tail risks include an ORCL multi-billion-dollar write-down, a GPU demand shock if enterprise AI projects pause, or a regulatory/marketing probe spilling into brand names — each capable of a >15% move for single names and adding 10–30 bps of risk-off pressure to Treasury yields over short windows. Immediate horizon (days): volatility spikes and paired unwind; short-term (weeks–months): guidance resets and positioning-driven squeezes; long-term (quarters+): fundamental AI adoption likely resumes unless capex is structurally curtailed.

Trade implications: Tactical opportunities favor asymmetric structures: buy 1–3 month call spreads on NVDA/AVGO as momentum recovers, and hedge with 2–4% notional ORCL put spreads (3–6 month) to protect against execution risk. Consider pair trades (long AVGO, short ORCL) to isolate AI hardware exposure vs execution risk, and use calendar spreads/short-dated puts to monetize elevated near-term IV.

Contrarian angles: The market is conflating an idiosyncratic ORCL datapoint with a broad AI demand collapse — if NVDA/AVGO dip 8–12% without negative fundamental updates, that is a high-conviction buying window (3–6 month horizon). Historical parallels (2019–21 tech pullbacks) show leadership typically reasserts within 3–6 months; beware liquidity squeezes in concentrated ETFs and watch ORCL earnings/announcements as the binary catalyst in 30–60 days.

Key Decisions for Investors

• Establish a 2–3% portfolio long in NVDA via a 3-month 5–10% OTM call spread (buy 1 5% OTM call, sell 1 10% OTM call) targeting +20% upside in 3–6 months; hard stop-loss if NVDA falls >12% intraday after entry.
• Initiate a 1–2% notional bearish hedge on ORCL with a 3–6 month 8/18% ITM/OTM put spread (buy deeper ITM put, sell OTM) sized to cap downside from a potential multi-billion write-down; reassess after next quarterly guidance (within 30–45 days).
• Run a relative-value pair: long 1% AVGO equity (or 3-month call spread) and short 1% ORCL equity to isolate semiconductor/AI hardware exposure from Oracle execution risk; rebalance if spread widens >6% or after ORCL event.
• Rotate 2–4% from pure-play AI/software names into defensive tech/semis (AVGO) and selective cyclicals (TSLA) over the next 2 weeks; add to longs if leaders drop an additional 8–12% absent negative fundamental updates and trim if a reversal exceeds +15%.